The HIV Drugs Market is expected to grow steadily from 2025 to 2035, driven by advancements in antiretroviral therapy and increasing global awareness initiatives. Rising HIV prevalence, improved ...

Truvada was also the overall highest-selling drug on the market for the treatment of HIV in 2006 ... such as Aurobindo and Cipla, have developed and received FDA approval for several other ...

In the following year, Cipla received approval from United States Food and Drug Administration (USFDA) to manufacture medicines in bulk for HIV. In 1994, Cipla introduced Deferiprone which was sta ...

"Formosa Pharma welcomes this partnership with Cipla, a well-renowned and respected global pharmaceutical brand. We appreciate their recognition and desire to add APP13007 to their rich portfolio ...

“This includes HIV drugs - a large part of spending for treatment ... Aurobindo Pharma Ltd and Cipla Ltd, also tumbled on Monday. The Nifty Pharma index closed 2.65% lower.

Efforts to get Gilead’s experimental COVID-19 drug remdesivir to patients in badly-hit India are building after drug maker Cipla announced it had launched the drug in the country. The ...

Cipla Ltd. has expressed optimism about exceeding ... has instructed organizations in other countries to stop disbursing HIV medications purchased with US aid, even if the drugs have already ...